The group will test its immunostimulant Shrimp IMS feed additive in Vietnam, one of the world's four largest shrimp producing countries. IMS is administered through the entire shrimp life cycle to protect it against a range of diseases.
The latest news follows the contract awarded to the company earlier in the year to supply shrimp-disease diagnostic kits to government laboratories throughout the country. Vietnam's shrimp farmers have suffered in recent years as shrimp harvests have been considerably reduced by disease.
The commercial effectiveness of Shrimp IMS has been proven in Mexico and Ecuador, as well as in numerous lab and field trials, said Aqua.
Source: Sharecast